172 related articles for article (PubMed ID: 30702927)
1. AICAr suppresses cell proliferation by inducing NTP and dNTP pool imbalances in acute lymphoblastic leukemia cells.
Du L; Yang F; Fang H; Sun H; Chen Y; Xu Y; Li H; Zheng L; Zhou BS
FASEB J; 2019 Mar; 33(3):4525-4537. PubMed ID: 30702927
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
[TBL] [Abstract][Full Text] [Related]
3. Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression.
Igata M; Motoshima H; Tsuruzoe K; Kojima K; Matsumura T; Kondo T; Taguchi T; Nakamaru K; Yano M; Kukidome D; Matsumoto K; Toyonaga T; Asano T; Nishikawa T; Araki E
Circ Res; 2005 Oct; 97(8):837-44. PubMed ID: 16151020
[TBL] [Abstract][Full Text] [Related]
4. AMPK and Akt determine apoptotic cell death following perturbations of one-carbon metabolism by regulating ER stress in acute lymphoblastic leukemia.
Kuznetsov JN; Leclerc GJ; Leclerc GM; Barredo JC
Mol Cancer Ther; 2011 Mar; 10(3):437-47. PubMed ID: 21262957
[TBL] [Abstract][Full Text] [Related]
5. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
[TBL] [Abstract][Full Text] [Related]
6. 5-aminoimidazole-4-carboxamide riboside enhances effect of ionizing radiation in PC3 prostate cancer cells.
Isebaert SF; Swinnen JV; McBride WH; Begg AC; Haustermans KM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1515-23. PubMed ID: 21944462
[TBL] [Abstract][Full Text] [Related]
7. 5-amino-4-imidazolecarboxamide riboside potentiates both transport of reduced folates and antifolates by the human reduced folate carrier and their subsequent metabolism.
McGuire JJ; Haile WH; Yeh CC
Cancer Res; 2006 Apr; 66(7):3836-44. PubMed ID: 16585211
[TBL] [Abstract][Full Text] [Related]
8. The ribonucleoside AICAr induces differentiation of myeloid leukemia by activating the ATR/Chk1 via pyrimidine depletion.
Dembitz V; Tomic B; Kodvanj I; Simon JA; Bedalov A; Visnjic D
J Biol Chem; 2019 Oct; 294(42):15257-15270. PubMed ID: 31431503
[TBL] [Abstract][Full Text] [Related]
9. Activation of AMP-activated protein kinase suppresses oxidized low-density lipoprotein-induced macrophage proliferation.
Ishii N; Matsumura T; Kinoshita H; Motoshima H; Kojima K; Tsutsumi A; Kawasaki S; Yano M; Senokuchi T; Asano T; Nishikawa T; Araki E
J Biol Chem; 2009 Dec; 284(50):34561-9. PubMed ID: 19843515
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics identifies pyrimidine starvation as the mechanism of 5-aminoimidazole-4-carboxamide-1-β-riboside-induced apoptosis in multiple myeloma cells.
Bardeleben C; Sharma S; Reeve JR; Bassilian S; Frost P; Hoang B; Shi Y; Lichtenstein A
Mol Cancer Ther; 2013 Jul; 12(7):1310-21. PubMed ID: 23585020
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).
Zhuge J
Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with 5-amino-4-imidazolecarboxamide riboside and arsenic trioxide in acute myeloid leukemia cells involving AMPK/TSC2/mTOR pathway.
Chen L; Han F; Qu H; Yan H; Ren L; Yang S
Pharmazie; 2013 Feb; 68(2):117-23. PubMed ID: 23469683
[TBL] [Abstract][Full Text] [Related]
13. AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cells.
Santidrián AF; González-Gironès DM; Iglesias-Serret D; Coll-Mulet L; Cosialls AM; de Frias M; Campàs C; González-Barca E; Alonso E; Labi V; Viollet B; Benito A; Pons G; Villunger A; Gil J
Blood; 2010 Oct; 116(16):3023-32. PubMed ID: 20664053
[TBL] [Abstract][Full Text] [Related]
14. AICAR induces Bax/Bak-dependent apoptosis through upregulation of the BH3-only proteins Bim and Noxa in mouse embryonic fibroblasts.
González-Gironès DM; Moncunill-Massaguer C; Iglesias-Serret D; Cosialls AM; Pérez-Perarnau A; Palmeri CM; Rubio-Patiño C; Villunger A; Pons G; Gil J
Apoptosis; 2013 Aug; 18(8):1008-16. PubMed ID: 23605481
[TBL] [Abstract][Full Text] [Related]
15. The activation of the p53 pathway by the AMP mimetic AICAR is reduced by inhibitors of the ATM or mTOR kinases.
Zajkowicz A; Rusin M
Mech Ageing Dev; 2011; 132(11-12):543-51. PubMed ID: 21945951
[TBL] [Abstract][Full Text] [Related]
16. Combined Treatment of MCF-7 Cells with AICAR and Methotrexate, Arrests Cell Cycle and Reverses Warburg Metabolism through AMP-Activated Protein Kinase (AMPK) and FOXO1.
Fodor T; Szántó M; Abdul-Rahman O; Nagy L; Dér Á; Kiss B; Bai P
PLoS One; 2016; 11(2):e0150232. PubMed ID: 26919657
[TBL] [Abstract][Full Text] [Related]
17. AMP-activated protein kinase inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells.
Jia F; Wu C; Chen Z; Lu G
Cardiovasc Drugs Ther; 2011 Feb; 25(1):21-9. PubMed ID: 21258964
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory activities of fenoterol through β-arrestin-2 and inhibition of AMPK and NF-κB activation in AICAR-induced THP-1 cells.
Wang W; Chen J; Li XG; Xu J
Biomed Pharmacother; 2016 Dec; 84():185-190. PubMed ID: 27657826
[TBL] [Abstract][Full Text] [Related]
19. Effect of the AMP-kinase modulators AICAR, metformin and compound C on insulin secretion of INS-1E rat insulinoma cells under standard cell culture conditions.
Langelueddecke C; Jakab M; Ketterl N; Lehner L; Hufnagl C; Schmidt S; Geibel JP; Fuerst J; Ritter M
Cell Physiol Biochem; 2012; 29(1-2):75-86. PubMed ID: 22415077
[TBL] [Abstract][Full Text] [Related]
20. The influence of the BRAF V600E mutation in thyroid cancer cell lines on the anticancer effects of 5-aminoimidazole-4-carboxamide-ribonucleoside.
Choi HJ; Kim TY; Chung N; Yim JH; Kim WG; Kim JA; Kim WB; Shong YK
J Endocrinol; 2011 Oct; 211(1):79-85. PubMed ID: 21795305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]